Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spironolactone
Laura Carone, Stephen G. Oxberry, Robert Twycross, et al.
Journal of Pain and Symptom Management (2016) Vol. 53, Iss. 2, pp. 288-292
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs
Michael Kaiser, Rama Abdin, Simonetta I. Gaumond, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 1387-1406
Open Access | Times Cited: 42
The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review
Chaofan Wang, Yimei Du, Lingbo Bi, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 603-612
Open Access | Times Cited: 24
Structural insights into human organic cation transporter 1 transport and inhibition
Shuhao Zhang, Angqi Zhu, Fang Kong, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 15
Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker (MRB) in hypertension and chronic kidney disease
Ningning Wan, Asadur Rahman, Akira Nishiyama
Journal of Human Hypertension (2020) Vol. 35, Iss. 2, pp. 148-156
Closed Access | Times Cited: 53
Pharmacology and drug interactions with HIV PrEP in transgender persons receiving gender affirming hormone therapy
Jenna Yager, Peter L. Anderson
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 6, pp. 463-474
Closed Access | Times Cited: 31
Sulfated and Sulfur-Containing Steroids and Their Pharmacological Profile
Tatyana A. Pounina, Tatyana A. Gloriozova, Nick Savidov, et al.
Marine Drugs (2021) Vol. 19, Iss. 5, pp. 240-240
Open Access | Times Cited: 24
Spironolactone as an adjuvant treatment for COVID-19: a systematic review and meta-analysis
Arman Shafiee, Mohammad Javad Amini, M. Rafiei, et al.
Future Virology (2025), pp. 1-8
Closed Access
Model-Informed Dose Optimization of Spironolactone in Neonates and Infants
Amira Soliman, Leandro Francisco Pippa, Jana Lass, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 355-355
Open Access
Trends in the Proportion of Young Women and Girls Prescribed Spironolactone
Sarah E. Soppe, Whitney R. Robinson, Mark P. Lachiewicz, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e250842-e250842
Open Access
Spironolactone inhibits the NLRP1 inflammasome and alleviates defective erythropoiesis in Diamond‐Blackfan anemia
Lola Rodríguez‐Ruiz, Juan M Lozano‐Gil, María Ocaña‐Esparza, et al.
HemaSphere (2025) Vol. 9, Iss. 4
Open Access
Insight into the Adsorption and Inhibitive Effect of Spironolactone Drug on C38 Carbon Steel Corrosion in Hydrochloric Acid Environment
N. J. Maduelosi, Nkem B. Iroha
Journal of Bio- and Tribo-Corrosion (2020) Vol. 7, Iss. 1
Closed Access | Times Cited: 26
Spironolactone in dermatology
Diana Alejandra Aguilar Medina, Jorge Cazarín, Mario Magaña
Dermatologic Therapy (2022) Vol. 35, Iss. 5
Open Access | Times Cited: 14
Spironolactone Ameliorates Senescence and Calcification by Modulating Autophagy in Rat Tendon‐Derived Stem Cells via the NF‐κB/MAPK Pathway
Kai Xu, Changjian Lin, Diana Ma, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 18
The Effects of Different Classes of Antihypertensive Drugs on Patients with COVID-19 and Hypertension: A Mini-Review
Farnoosh Nozari, Nasrin Hamidizadeh
International Journal of Hypertension (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 10
A Simple Guide for Simple Orchiectomy in Transition-Related Surgeries
Courtney E. Francis, Ethan D. Grober, Emery Potter, et al.
Sexual Medicine Reviews (2020) Vol. 8, Iss. 3, pp. 492-496
Closed Access | Times Cited: 11
Current and emerging treatment options for central serous chorioretinopathy
Massimiliano Borselli, Costanza Rossi, Domenico Chisari, et al.
Expert Review of Ophthalmology (2024) Vol. 19, Iss. 4, pp. 247-260
Open Access | Times Cited: 1
Spironolactone use and oocyte maturation in patients undergoing controlled ovarian hyperstimulation
Atoosa Ghofranian, Samantha L. Estevez, Bethany Dubois, et al.
Journal of Assisted Reproduction and Genetics (2024) Vol. 41, Iss. 8, pp. 1991-1996
Closed Access | Times Cited: 1
Clinical Care of Acne Vulgaris for Transgender and Gender Diverse Youth
Adam Zimmer, Juanita K. Hodax, Andrea L. Zaenglein, et al.
Pediatrics in Review (2024) Vol. 45, Iss. 11, pp. 613-624
Closed Access | Times Cited: 1
Natural sulphur-containing steroids: Origin and biological activities
Valery M. Dembitsky, Nick Savidov, Tatyana A. Gloriozova
Vietnam Journal of Chemistry (2018) Vol. 56, Iss. 5, pp. 533-541
Open Access | Times Cited: 6
Otorhinolaryngological adverse effects of urological drugs
Nathalia de Paula Doyle Maia, Karen de Carvalho Lopes, Fernando Freitas Ganança
International braz j urol (2021) Vol. 47, Iss. 4, pp. 747-752
Open Access | Times Cited: 5
High‐dose spironolactone lacks effectiveness in treatment of fibromyalgia (RCT)
Ruwen Böhm, Paul Westermann, Martin Gleim, et al.
European Journal of Pain (2021) Vol. 25, Iss. 8, pp. 1739-1750
Open Access | Times Cited: 5
Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease
Apostolis Papaefthymiou, Michael Doulberis, Kyriaki Karafyllidou, et al.
Minerva Endocrinology (2021) Vol. 48, Iss. 3
Closed Access | Times Cited: 5
New Spiro[cycloalkane-pyridazinone] Derivatives with Favorable Fsp3 Character
Csilla Sepsey Für, Hedvig Bölcskei
Chemistry (2020) Vol. 2, Iss. 4, pp. 837-848
Open Access | Times Cited: 4
Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis—An In Vitro Study
Eszter Fidrus, Csaba Hegedűs, Eszter Anna Janka, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1638-1638
Open Access | Times Cited: 4
Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation
Manasa Tatipalli, Vijay Kumar Siripuram, Tao Long, et al.
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 849-849
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top